Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 12
Submit an article Journal homepage
575
Views
47
CrossRef citations to date
0
Altmetric
Letters to the Editor

Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis

Marine BaronDepartment of Immunology, Saint Louis Hospital, Paris, France;
,
Jean Marc ZiniDepartment of Haematology, Saint Louis Hospital, Paris, France;
,
Thibaut Challan BelvalDepartment of Infectious Diseases, Alpes Leman Hospital, Contamine sur Arve, France;
,
Marguerite VignonDepartment of Immunology, Saint Louis Hospital, Paris, France;
,
Blandine DenisDepartment of Infectious diseases, Saint Louis Hospital, Paris, France;
,
Alexandre AlanioDepartment of Mycology, Saint Louis Hospital, Paris, France; ;Department of Mycology, Paris Diderot University, Sorbonne Paris Cité, Paris, France; ;Molecular Mycologic Unit, National Reference Center of Invasive Mycoses and Antifungals, Pasteur Institute, Paris, France; ;CNRS URA3012, Paris, France
&
Marion MalphettesDepartment of Immunology, Saint Louis Hospital, Paris, France; Correspondence[email protected]
 show all
Pages 2981-2982 | Received 30 Jan 2017, Accepted 10 Apr 2017, Published online: 30 May 2017

References

  • Morrison VA. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best Pract Res Clin Haematol. 2010;23:145–153.
  • Morrison VA. Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies. Clin Infect Dis. 2014;59(Suppl 5):S360–S364.
  • Morabito F, Gentile M, Seymour JF, et al. Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target. Leuk Lymphoma. 2015;56:3250–3256.
  • Kahl BS, Gordon LI, Dreyling M, et al. Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium Workshop. Leuk Lymphoma. 2015;56:2505–2511.
  • Byrd JC, O’Brien S, James DF. Ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369:1278–1279.
  • Byrd JC, Brown JR, O’Brien S, et al. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med. 2014;371:213–223.
  • Jain P, Keating M, Wierda W, et al. Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib. Blood. 2015;125:2062–2067.
  • Wang ML, Blum KA, Martin P, et al. Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood. 2015;126:739–745.
  • Ruchlemer R, Ben Ami R, Lachish T. Ibrutinib for chronic lymphocytic leukemia. N Engl J Med. 2016;374:1593–1594.
  • Okamoto K, Proia LA, Demarais PL. Disseminated cryptococcal disease in a patient with chronic lymphocytic leukemia on ibrutinib. Case Rep Infect Dis. 2016;2016:4642831.
  • Kreiniz N, Bejar J, Polliack A, et al. Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma. Hematol Oncol. 2017. DOI:10.1002/hon.2387
  • Herbst S, Shah A, Mazon Moya M, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240–258.
  • Karki R, Man SM, Malireddi RKS, et al. Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection. Cell Host Microbe. 2015;17:357–368.
  • Szymczak WA, Davis MJ, Lundy SK, et al. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans infection. MBio. 2013;4. DOI:10.1128/mBio.00265-13
  • Vetrie D, Vořechovský I, Sideras P, et al. Pillars article: the gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases. Nature. 1993;361:226–233.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.